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Autism is a neurodevelopmental disorder marked by pervasive impairments in 
behavior that manifest by three years of age, and sometimes earlier (American 
Psychological Association (APA), 1994). The characteristic behavioral impairments 
include hyperactivity, highly repetitive behaviors, emotional indifference, and lack of 
social engagement and reciprocity. Although affliction rates stand as high as 1 to 2 of 
every 1,000 individuals, and approximately $3 billion is expended yearly on research 
and social care, no definitive cause of the disorder has been identified (National 
Institute of Mental Health [NIMH], 2003). In recent years, however, neuroimaging and 
biochemical techniques have elucidated the pathophysiologic underpinnings that relate 
to the inability to exhibit typical socially- and emotionally-relevant behaviors (for 
review see Sweeten, Posey, Shekhar, & McDougle 2002). Face processing, when facial 
features are analyzed in order to extract social or emotional information, is one such 
behavior that is paramount to social interaction, and is impaired in autistics. 
Humans have evolved mechanisms that allow them to perceptually analyze a 
face, particularly the expression it holds (Grelotti, Gaussier, & Schultz, 2002). During 
facial analysis, emotions and social signals are spontaneously extracted. Utilizing 
infrared corneal reflection techniques that follow eye movement as processing occurs, 
research has established that normal individuals use configural processing in face 
analysis (Pelphrey, Sasson, Reznick, Paul, Goldman, & Piven, 2002). Specifically, an 
individual directs most attention to the eyes, nose, and mouth, with approximately 70% 
of this attention focused on the eyes (Pelphrey et al., 2002). In contrast, visual scanpath 
observations during autistic face processing demonstrate a different analysis strategy. 
Little to no attention is directed toward the eyes or the nose; instead, autistics scan the 
mouth and lower, non-feature regions of the face. Consequently, when pictures are 
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presented depicting a facial expression of one of the six universally-basic human 
emotions (happiness, sadness, fear, anger, surprise, disgust) (Ekman, 1992), autistics 
engage in non-configural (or segmental) processing and misidentify the depicted 
emotion 30% of the time (note: 30% is seemingly low for misidentification; this issue 
will later be clarified) (Pelphrey et al., 2002). The percentage of misidentification 
increases in proportion to an increase in the demanding nature or emotional weight of 
the task (Grelotti et al., 2002). Further, autistics fixate on faces for significantly shorter 
periods of time in comparison to healthy individuals (Pelphrey et al., 2002). 
Interestingly, facial recognition is the only form of facial perception that shows little to 
no impairment among autistics. 
The crucial factor that impairs the face-processing strategy in autism, while 
leaving facial recognition abilities intact, is the presence of emotional and social 
information (Grelotti et al., 2001). In recent years, functional neuroimaging and 
biochemical studies have elucidated the neuroanatomical structures active during 
emotional and social perception (Davidson and Slagter, 2000; Haznedar, Buchsbaum, 
Wei, Hof, Cartwright, & Bienstock, 2000). Moreover, differences have been localized 
and qualified that distinguish healthy from autistic participants (Narumoto, Okada, 
Sadato, Fukui, & Yonekura, 2001; Sweeten et al., 2002). The neural substrates of 
emotion have been identified by presenting affective stimuli while neuroimaging 
techniques record regional activity (Hall, Szechtman, & Nahmias, 2003). Facial 
expressions are the most widely utilized form of affective stimuli, for they arguably 
carry the greatest social and emotional import (Davidson et al., 2000; Narumoto et al., 
2001; Hall et al., 2003; Fudge and Emiliano, 2003).  
An added benefit of using facial presentation arises from the fact that different 
facial expressions can impart strong, moderate, or absent emotional information. 
Therefore, specific regions have been established as the substrates of emotional 
processing by comparing two forms of task-related neuroimaging scans: those that 
show neural activity during the presentation of emotional expressions, and those that 
show neural activity during the presentation of neutral faces (Narumoto et al., 2001). 
These scans have implicated an area of the cerebral cortex, the right superior temporal 
sulcus (STS), as the region active during emotional processing of faces (Narumoto et 
al., 2001; Hall et al., 2003). Activity is enhanced in the STS in response to the selective 
attention of healthy participants to facial emotion. In contrast, non-emotional attention 
elicits no response from the STS. 
Other lines of research converge on the STS as a substrate for social perception 
activities such as face-processing. Intercranial recordings of single cells located in the 
rostral/dorsal portion of the right STS highlight clusters of neurons that respond solely 
to expression (Narumoto et al., 2001). Related research demonstrated that electrical 
stimulation of these clustered neurons impairs the ability to accurately identify 
expressions. The expression-responsive neurons are therefore thought to comprise a 
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sensory processing area of the temporal lobe (Iacoboni, Koski, Brass, Bekkering, 
Woods, Dubeau, et al., 2001). This area essentially receives visual information, to 
which it then connects semantic meanings. The STS is also active during related forms 
of interpersonal communication such as following the eye gaze of others. It is therefore 
noteworthy that the activated cluster of neurons lies near the V5/MT brain region 
(Visual Area 5), which is responsible for the perception of moving visual stimuli 
(Iacoboni, 2001; Narumoto et al., 2001). Consequently, the ability to perceive 
emotional expressions as they change occurs due to axonal connections that allow for 
communication between the right STS and V5/MT brain regions. 
The above neuroimaging studies on neural activity during facial presentation 
establish the conclusion that the right STS functions during fine-grained spatial 
processing. This is precisely the form of processing that is necessary for expert facial 
analysis. Moreover, the STS responds specifically to facial stimuli as the face imparts 
social and emotional information, usually through expressions. As discussed 
previously, autistics engage in segmental face-processing that ignores the eyes and 
nose, thereby extracting little socially- and emotionally-relevant cues from expressions 
(Pelphrey et al., 2002). Consequently, the finding is logical that autistics demonstrate 
impaired function in the right STS (for review see Davidson and Slagter, 2000). 
Research examining the functional and structural differences of the STS has continued 
to utilize facial presentations. Hall, Szechtman, and Nahmias (2003) examined levels of 
glucose metabolism using positron emission tomography (PET) in concordance with 
the presentation of facial emotions. PET scans record the amount of activity in a region 
based on glucose metabolism. A task involving the identification of sex from 
emotionally-neutral faces was included to establish which neural regions respond 
when visual stimuli provide no emotional information. As expected, significantly less 
activation was witnessed in the autistic STS in comparison to healthy participants. 
Instead, the thalamus within autistics functioned as greatly in response to facial 
presentations as did the STS in the control group.  
The thalamus demonstrates increased activity due to the segmental face-
processing approach utilized in autism. The segmental approach is neither effortless 
nor spontaneous (in comparison to the effortless configural approach of healthy 
individuals) (Grelotti et al., 2001). Instead, it assembles sensory information from 
numerous sources rather than from solely the eyes and nose. In turn, greater functional 
strain is imposed on the thalamus, which modulates the sensory processing system. As 
previously discussed, autistics presented with facial expressions depicting one of the 
six basic human emotions misidentify the emotion 30% of the time (Pelphrey et al., 
2002). This figure appears low based on the characteristic inability of an autistic to 
retrieve facial emotional information. However, autism is not a degenerative disorder. 
Therefore, most autistic individuals are capable of learning compensatory strategies for 
their emotional and social deficits (NIMH, 2003). Segmental face-processing, in 
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concordance with greater thalamic activation, is one such strategy. This strategy is 
obviously not perfect, for autistics continue to demonstrate gross impairments in social 
and emotional interaction (Hall et al., 2003). However, with practice many are capable 
of distinguishing the most basic of emotions: happiness and sadness. Thus, a 30% 
misidentification rate denotes the underlying difficulties that autistics continue to have 
in deciphering more complex expressions such as surprise and disgust.
Within autism, the compensatory use of the thalamus suggests a malfunction in 
the emotion-linked sensory processing system on which normal individuals rely. 
Structural damage of the STS would seem the most logical conclusion. However, 
postmortem examinations and Magnetic Resonance Imaging (MRI) scans have 
determined that the volume and structure of the STS are not abnormal within autistic 
individuals (Rapin and Katzman, 1998; Sweeten et al., 2002). On the other hand, 
numerous studies utilizing neuroimaging techniques have discovered that the autistic 
amygdala and hippocampus are anatomically abnormal (Rapin and Katzman, 1998; 
Aylward, Minshew, Goldstein, Augustine, & Yates, 1999; Sweeten et al., 2002; Hall et 
al., 2003). The amygdala and hippocampus are two of several structures that comprise 
the limbic system, which is implicated in memory, learning, emotion, and motivation. 
MRI scans of the autistic amygdala displayed decreased neuronal size, increased 
neuronal packing, decreased dendritic extensions, and small cell bodies (Aylward et 
al., 1999). Consequently, amygdala volumes, both before and after correction for total 
brain volume, are greatly reduced in autism. The hippocampus has shown similar 
patterns of deformity to the amygdala. Interestingly, children with diseases that damage 
the limbic system, such as viral encephalitis, tuberous sclerosis, and cancer, exhibit 
autistic-like symptoms (Sweeten et al., 2002). Therefore, limbic system dysfunction is 
most likely at the root of autism. 
 Convergent research has further demonstrated that amygdala, rather than 
hippocampal, abnormality is responsible for emotionally-relevant face-processing 
deficits among autistic individuals. The hippocampus is active during tasks of learning 
and memory. On the other hand, motivation, emotional recognition, and displays of 
aggression elicit amygdala activity. However, PET scans tracing regional cerebral blood 
flow (rCBF) among autistics have failed to find increased amygdala activity in 
response to the presentation of facial expressions (Davidson and Slagter, 2000). In 
particular, healthy individuals demonstrate greatest activity in response to fear. 
However, in the study among autistic individuals who misidentified emotions 30% of 
the time, an average of 70% of those misidentifications were between fear and anger 
(Pelphrey et al., 2002). Another behavioral characteristic of autism is the bizarre, erratic 
display of aggression directed both inward and outward (APA, 1994). Thus, both the 
inability to detect fear in facial expressions and the characteristic random acts of 
aggression implicate amygdala abnormality as an underlying factor.  
 Amygdala response to motivation is also significant because the ability to 
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expertly discern the emotion of another individual is not innate. Face-processing, 
similar to any other task one seeks to master, requires extensive perceptual and 
cognitive attention and energy, and is motivated by the human drive for social 
interaction (Grelotti et al., 2002). In healthy individuals, the amygdala responds to 
motivating social interactions by releasing the feel-good neurotransmitter dopamine 
(DA) (Fudge and Emiliano, 2003). DA reinforces behaviors; consequently, healthy 
individuals strive to become experts in face-processing. This motivational drive is 
largely absent among autistics. One could argue that segmental face-processing, and 
thus use of the thalamus, demonstrates an autistic’s motivation for social interaction. 
However, as previously described, segmental face-processing is significantly shorter in 
duration than configural-processing. PET scans have found little to no anatomical 
abnormalities apparent in autistic attentional systems (Haznedar et al., 2000). This has 
led to the conclusion that lack of motivation, rather than a physical inability to attend, 
results in shorter processing during facial presentation (Pelphrey et al., 2002). One 
theory has consequently linked autistic lack of motivation to functional impairments of 
the DA system (Buitelaar, 2003). However, investigations into DA levels in autism have 
demonstrated few consistent results. Some studies examined DA levels in response to 
repetitive behaviors that an autistic individual finds pleasurable. The levels were no 
different in autism than in normal individuals, discrediting the possibility of autistic 
DA dysfunction. Findings, therefore, are consistent with the idea that amygdala 
abnormality underlies impairments in the connection of motivation to social 
interactions.  
The theory that amygdala deformity subsumes social deficits in autism is further 
evidenced by research examining the effects of experimental manipulations, natural 
diseases, and injuries (Sweeten et al., 2002; Fudge and Emiliano, 2003). Monkeys are 
commonly utilized in experimental research due to the similarity of their neural system 
to that of humans. One study elicited over-stimulation in the basolateral nucleus of the 
amygdala (BLA) using stress-associated peptide corticotropin-releasing factor (CRF) 
(Sweeten, et al., 2002). In normal individuals, as CRF levels rise, the BLA is excited, 
and a deficit in typical social behaviors is demonstrated. Likewise, in this study 
intentional over-stimulation resulted in severe and chronic disruption of social 
interaction behaviors. Another study examined the effects of hippocampal versus 
amygdala lesions, with striking support for amygdala damage in concordance with 
autistic symptoms (Sweeten et al., 2002). Lesions of the monkey amygdala by two 
months of age produced disturbances in social and emotional functioning similar to the 
patterns seen in autism. Hippocampal lesions resulted in similar disturbances; however, 
by six months of age any deficits had disappeared. This occurrence conflicts with the 
stable pattern of deficits in behavior that are observed among autistic individuals. 
Thus, the theory that hippocampal abnormalities result in autistic social dysfunction 
has been discredited. 
In light of the aforementioned evidence, it is clear that structural abnormality 
within the amygdala is the most likely source of social impairments in autism. It must 
be noted, however, that not all research has found the presence of amygdala 
deformities (Haznedar et al., 2000). MRI scans compared limbic structure volumes 
within 17 autistic and 15 control participants. No differences were noted. Also, a PET 
scan of rCBF during a verbal learning test found little to no difference among 
structural functioning. In comparison to numerous other studies documenting 
amygdala abnormality, the MRI results cannot be explained. The counterfactual PET 
results, however, appear to be due to the nature of the task. A verbal learning test 
would not ordinarily activate the amygdala (unless, possibly, some emotionally-
relevant words are selected). If anything, previous findings suggest that the 
hippocampus instead would be activated, yet in this study it is not. The present 
research seeks to produce anatomical abnormalities in the amygdala, and to then record 
rCBF during the viewing of facial expressions. By doing so, a direct connection can be 
established between the sole presence of amygdala abnormalities and the impairment in 
social activities such as facial analysis.  
Anatomic organization between the socio-emotional and the sensory system 
places the amygdala at the center of emotional perception in both humans and primates 
(Lane and Nadel, 2000; Fudge and Emiliano, 2003). The basolateral nuclear group 
(BLNG), located within the BLA, is the primary receiving portion of the amygdala. It is 
connected to axonal projections from the temporal cortex, including the STS, the 
orbital and medial prefrontal cortex (OMPFC), and the hippocampus. Initial perception 
of higher-order stimuli, such as facial expression, activates the STS. The OMPFC 
determines the relative reward value of the visual stimuli, with the hippocampus 
recording this value for future reference. Any emotionally-relevant information 
regarding the facial expression is then projected by each structure to the BLNG. 
Finally, the BLNG engages in the deepest socio-affective processing of the facial 
expression by integration of the information received.  
As discussed previously, MRI and postmortem examinations have found 
moderate to severe structural abnormalities in autistic amygdala (Aylward et al., 1999). 
Due to the role that the amygdala is evidenced to play in social and emotional 
engagement, the next crucial step is to determine the connection between its structural 
abnormality and autistic impairments. Deformity includes dense neuronal packing, 
which appears to explain the other deformities of decreased dendritic complexity, small 
cell bodies, and highly complicated axonal pathways. Consequently, the prevailing 
theory for autistic amygdala deformity proposes a deficit in neuronal pruning during 
early development (Rapin and Katzman, 1998; Aylward et al., 1999). At birth, 
approximately 20-80% of neurons in each region are excessive. Neurons compete for 
synaptic targets, through which they receive nourishing neurotrophic factors. Neurons 
that either receive inadequate amounts of neurotrophic factor, or are useless due to a 
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lack of synaptic connections, engage in programmed cell death (apoptosis). During 
apoptosis, the neuron activates death genes, which allow caspases to dissolve the 
chromatin composition of the neuron. The excessive 20-80% of neurons in each region 
engage in programmed cell death. This process is referred to as neural pruning, the 
majority of which occurs during the first 10 to 35 weeks of life (for review see 
Jacobson, 1991). 
The result of dysfunctional apoptosis mirrors the structural abnormality 
displayed in the autistic amygdala. In particular, neuronal packing produces stunted 
dendritic arborization, where the dendrites projecting from the end of axons are too 
crowded to properly expand. The theoretical consequence of stunted dendritic 
arborization is an interference in messages relayed from connected regions, including 
the STS, hippocampus, and OMPFC. This is consistent with previously-described 
research that the autistic BLNG fails to integrate emotionally-relevant information 
received from other structures. Further, the chronological pattern of deficit appearance 
in autism begins as early as 12 months, as evidenced by impairments in gaze following 
(Grelotti et al., 2002). This pattern coincides with the timeline of apoptosis that 
normally allows proper, functional synapses to be established by 12 months.  
It must be noted that the present hypothesis does not attempt to explain all the 
socio-emotional deficits within autism as arising from amygdala dysfunction. 
However, the neural system is integrated in such a manner that the more diffusely 
abnormal a structure, the greater the malfunction of connected systems (Rapin and 
Katzman, 1998). Therefore, the dysfunction of even one integral structure (in this case, 
the amygdala) can have profound negative effects on activity in the rest of the brain. 
As discussed, numerous lines of research support the theory that amygdala abnormality 
due to faulty neuronal pruning subsumes autistic impairments in social interaction and 
emotion. However, current neuroimaging studies that reveal autistic amygdala 
abnormality do so in hindsight of the appearance of deficits (Haznedar et al., 2000). 
Thus, a crucial piece of the puzzle is to determine whether structural changes in the 
amygdala elicit socio-emotional impairments. The alternative theory (which receives 
little support) is that behavioral deficits alter the amygdala structure. However, 
experimental manipulations of this theory have yet to be conducted for ethical and 
practical reasons. No genetic or environmental marker has been discovered that 
predicts the onset of autism. Thus, it has been unethical to clinically interfere with the 
development of the amygdala within human subjects. However, neuronal packing in 
the amygdala will only be definitively proven a substrate of autism once science is 
given the opportunity to interfere. Interestingly, the application of neurotrophic factor 
has been demonstrated to significantly decrease apoptosis (Jacobson, 1991). This 
crucial point provides a means through which amygdala abnormality can be 
experimentally induced among non-human subjects. 
In light of the aforementioned practical and ethical concerns, experimental 
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manipulation of the macaque monkey (Macaca fuscata) is the next necessary step. The 
use of non-human subjects removes numerous extraneous variables that normally must 
be considered within theories of autism. Among humans, such variables as IQ, drug 
treatment, and varied environments can affect the level of autistic deficits or neural 
structures. Manipulations in the macaque are generalizeable to humans due to the fact 
that the primate neural structure highly mirrors that of humans (Lane and Nadel, 2000). 
Specifically, the STS processes socially-relevant information, which is then 
communicated through axonal projections to the lateral amygdala. The amygdala in 
turn engages in deep emotional processing of sensory stimuli. Possibly due to the 
parallel organization of human and macaque structures, macaques demonstrate 
numerous socially-interactive behaviors. They exhibit and act on fear (Lane and Nadel, 
2000), respond to others, engage in gaze-following (Ferrari, Kohler, Fogassi, & 
Gallese, 2000), and most importantly, discern facial expressions through configural-
processing (Sweeten et al.; 2002). Similar to humans, gaze following and configural-
processing abilities increase with age as socially-interactive behaviors are reinforced 
(Ferrari et al., 2000). Lesion studies of monkeys, which examine intentional or 
incidental abnormalities in structure, have consequently facilitated an understanding of 
the role of the amygdala in normal social and emotional processing (Lane and Nadel, 
2000; Sweeten et al., 2002). Amygdala lesions early in life elicited autistic-like 
characteristics among macaques, including little eye contact, lack of interest in face-
processing, and decreased display of facial expressions.  
These findings are consistent with the theory that amygdala abnormality among 
both humans and monkeys subsumes socio-emotional disturbances in autism. 
Consequently, the present research seeks to mimic autistic neuronal packing in the 
BLA portion of the amygdala through the application of neurotrophic factor. As 
described previously, neurons compete early in life for nourishing neurotrophic factor 
(for review see Jacobson, 1991). Those that receive it fail to engage in apoptosis. 
Therefore, application of neurotrophic factor greatly increases the number of surviving 
neurons, producing dense neuronal packing. It is hypothesized that later presentations 
of facial expressions will result in impaired face-processing, and that the impaired 
amygdala will display decreased activation in comparison to control monkeys. It is 
further hypothesized that no other structure will display impaired activity because 
neuronal packing will be manipulated solely in the amygdala. Should face-processing 
be impaired in accordance with only amygdala impairment, evidence will be 
established that a lack of neuronal pruning in the amygdala is responsible for social 




Approximately 8 macaque monkeys (7 weeks of age) will be used in the 
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proposed experiment. Of the 8, 4 will be experimental and 4 will be control, with an 
even number of males and females in each group. From the outset of the research, 
guidelines set forth by the Institutional Animal Use and Care Committee (IAUCC) will 
be followed for promoting the psychological well-being of the primates. They will be 
housed among non-experimental macaques in a mock-natural environment with the 
presence of natural visual, auditory, olfactory, and tactile stimuli. Further, decisions 
about combining or separating monkeys will be based on reducing territorial anxiety. 
All handlers will be selected based on prior training with primates, as established by 
the IAUCC. This enriched mock-environment will ensure that all 8 subjects are 
provided the opportunity to develop healthy social and emotional interactive 
behaviors.  
The 8 macaques will be examined prior to commencement of the experiment 
using MRI to ensure normal structural development. Macaques displaying abnormal 
development of any structure will be rejected from the subject pool. At approximately 
9.5 weeks of age, the BLA of 4 macaques will be outlined by 2 separate researchers 
through examination of the MRI scans. The 4 will be anesthetized. Guided by the 
location of the outlined amygdala, the macaques are to be injected with neurotrophic 
factor in order to suppress the occurrence of apoptosis. After a week has passed, an 
absolute and a relative amygdala volume will be calculated in cubic centimeters to 
determine the extent to which apoptosis has been suppressed. Whether further 
neurotrophic factor must be later administered (at the end of 15 weeks) will be 
determined by comparisons to the relative amygdala volume of controls. Also, other 
structural volumes will be compared to relative volumes in controls to ensure no 
abnormal neuronal changes, such as packing, have occurred. Subjects that demonstrate 
abnormal structural change other than in the amygdala will be removed from the 
subject pool. 
The project intends to use two forms of data collection regarding behavioral 
manifestations of each monkey. The first form of data will be observational, collected 
for the subsequent 45 weeks (at the end of which the monkeys will be 1 year of age). 
Handlers, blind to the identity of manipulated versus control monkeys, will record 
levels of daily social interaction behaviors using a 5-point scale. For each of 12 
behavioral questions, a score of 5 will represent the most active engagement in social 
behaviors. A score of 1 will represent no social behaviors. Points between 1 and 5 will 
represent a continuum of level of social behavior demonstrated. Recordings will be 
made for the dimensions of gaze following, empathy towards others, and helping 
behavior. Any stability or changes in social interaction behaviors will be identified by 
comparing weekly scores for each monkey to their scores from the prior week. 
Interrater reliability for each score will be assessed through use of the statistical 
program SPSS.  
This phase of data collection is obviously prone to human bias and error. 
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Therefore, the resulting data will be used solely to create a socio-emotional profile of 
behavior for each monkey. Two new raters, blind to the hypothesis of the experiment 
as well as the identity of each group member, will compile the scores of all 45 weeks. 
Monkeys who score 0-1080 at the end of the 45 weeks will be classified displaying 
autistic characteristics. Scores of 1081-1485 will be deemed borderline autistic 
characteristics. Finally, those with a score of 1486-2700 will be labeled displaying 
normal characteristics. The classification for each monkey will then be compared with 
whether the monkey is a member of the experimental or the control group. 
The second form of data collection will utilize neuroimaging and 
immunocytochemical techniques. At one year of age, MRI scans will demonstrate 
whether increased amygdala volume is still present among those monkeys treated with 
neurotrophic factor. Control and experimental subjects will then be presented 12 high-
resolution, monochromatic pictures of monkey faces, each depicting 1 of the 6 
different expressions. Each picture will remain for 7 seconds. The head and body of 
each monkey will be comfortably restrained so that only the eyes may move. Eye 
movement is monitored by an infrared corneal reflection technique to determine any 
differences in face-processing. For each picture, the direction of corneal attention on 
facial features will be recorded. Monkeys who demonstrate more than 50% fixation on 
non-configural features will be deemed segmental face-processors. Also, duration of 
facial-fixation will be recorded through the corneal reflection technique.  
In concordance with this face-processing task, functional Magnetic Resonance 
Imaging (fMRI) scans will record which neural structures are hemodynamically active 
(receiving higher levels of rCBF) in response to the presented emotionally- and 
socially-relevant facial expressions. FMRI, like PET, records the changing activity of 
neural regions. However, the advantage of fMRI over PET is that no injection is 
required in order to witness differences in activity. During a second presentation of 
expressions to both groups, the anterograde tracer biotinylated dextran amine (BDA) 
will be injected into the STS, OMPFC, and hippocampus. Research has demonstrated 
BDA to provide excellent and abundant labeling of axons and terminals (Veenman, 
Reiner, & Honig, 1992). In other words, BDA, as it is transported along axons to other 
neurons, provides excellent contrast for microscopically viewing axonal pathways. In 
the experimental group, the structures to which the tracers are transported will be 
compared to the healthy control group to determine if impairments exist in axonal 
connections innervating the amygdala. 
 
Findings and Significance 
 
 Social and emotional impairment in interactive behavior is the most 
characteristic manifestation of autism (APA, 1994). Numerous lines of research have 
suggested that structural abnormalities found in the amygdala, specifically among the 
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BLA, subsume this characteristic. However, to date studies have utilized powerful 
neuroimaging techniques to examine neural structures in hindsight of observed autistic 
impairments. The result of such techniques has demonstrated a strong correlation 
between autistic deficits and the presence of neural deformities. The present hypothesis 
proposes the crucial next step in determining whether amygdala abnormality due to 
faulty neuronal pruning subsumes autistic impairments in social interaction and 
emotion. 
This study will induce structural abnormality therefore macaque monkeys will 
be used. Results from a sample of macaque monkeys are generalizeable to humans 
because their neural structure mirrors that of humans. Consequently, it is expected that 
the application of neurotrophic factor at 9.5 weeks of age will suppress apoptosis in 
macaque monkeys, as it is shown to do in human neurons. The consequence will be a 
packing of neurons within the amygdala that parallels the presence of amygdala 
deformity demonstrated among autistic individuals. This deformity is expected to be 
observable in MRI scans of amygdala volumes conducted a week after administration 
of the neurotrophic factor. It is, however, possible that apoptosis in the amygdala does 
not normally occur until the lapse of a specific period of weeks after birth. Therefore, 
should MRI scans find relative amygdala volumes to be equal to that of controls, more 
neurotrophic factor will be administered. It is further expected that suppression of 
apoptosis will only occur in the amygdala, for the proposed research seeks to eliminate 
abnormalities in other neural structures as an explanation for autistic characteristics.  
The organization of the macaque emotional sensory processing system also 
mimics that of humans. Therefore, it is hypothesized that the induced structural 
abnormalities of macaques will elicit autistic-like impairments in social and emotional 
behavior. Scores obtained during the 45-week observational data collection period 
should reflect these impairments. Specifically, it is expected that experimental monkeys 
will demonstrate an initial decrease in scores from pre-manipulation levels, as well as 
in comparison to controls. Further, these monkeys should place into the displaying 
autistic characteristics classification. Each socio-emotional profile is expected to 
supplement the concrete data provided by corneal reflection techniques, and by fMRI 
scans of rCBF and microvascular oxygenation during facial expression presentations. 
During the exposure to faces, experimental macaques should show segmental facial 
analysis, as well as a decreased duration of fixation time. The fMRI scans should 
display relatively normal functioning among the affect-linked sensory system 
structures, including the STS, OMPFC, and hippocampus. Finally, it is expected that 
BDA tracers injected into the STS, OMPFC, and hippocampus will fail to properly 
follow the BLA axonal pathways utilized by controls.  
The finding that normal sensory processing occurs in non-amygdala structures, 
in correspondence with the existence of autistic-like behavioral impairments, will 
provide evidence for the hypothesis that the pathophysiologic underpinning of autism 
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lies within the amygdala. An inability for the BLA to axonally receive messages from 
higher-order sensory systems, as evidenced by abnormal transportation of BDA 
tracers, supports the subsequent hypothesis that neuronal packing impairs the BLA in 
integrating information. Experimentally suppressing apoptosis in the macaque 
amygdala is the next crucial step in determining the pathologic underpinning of autism. 
Such a determination will subsequently give rise to research regarding the exact origin 
of autistic neuronal packing in the amygdala. Unfortunately, a lack of advancements in 
neuroimaging and biochemical techniques currently prevents research from 
determining whether a genetic abnormality for apoptosis exists within the amygdala. 
One alternative explanation is that an excessive level of neurotrophic factor is released 
during early development, suppressing programmed neuronal death. It is the hope of 
this proposal that progress in the understanding of autism will motivate future 
researchers to develop these more advanced techniques.  
The present research will consequently play a significant role in the future of 
diagnosis, treatment, and possible preventative measures for autism. There is currently 
no gold standard with which to diagnose the presence of this disorder (Rapin and 
Katzman, 1998). A concrete understanding of its pathophysiology will allow such a 
standard to be created based on the presence of specific abnormalities, such as in the 
amygdala. Due to the fact that a diagnosis of autism often requires lifelong societal 
support, strenuous research has focused on curative treatments. Most medications have 
sought to alleviate the social and emotional impairments, such as segmental facial 
analysis, that hinder social reciprocity (Werry, 2001). Alternatives have targeted 
numerous sources such as neurotransmitter release, and the ability of the amygdala to 
integrate sensory information (Buitelaar, 2003). The latter treatment, a synthetic 
acetylcholine analogue called Org 2766, was found to facilitate significant 
improvements in eye-contact and social reciprocity. However, as with any other drug, 
Org 2766 has emotionally-aggravating side-effects such as agitation and irritability. It is 
clear that the future of research, including the present proposal, must elucidate the 
physiological abnormalities within autism. Only with such an understanding can 
preventive measures begin to fight such drastic and heartbreaking impairments as an 
inability to draw social and emotional clues from a facial expression.  
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